Saturday, October 23, 2021
Home Search

cadila - search results

If you're not happy with the results, please do another search
USFDA

USFDA gives tentative nod to Zydus Cadila for Adapalene and Benzoyl Peroxide Gel

Zydus Cadila has received tentative approval from the US Food and Drugs Administration (USFDA) to market Adapalene and Benzoyl Peroxide Gel 0.3%/2.5%....
Zudus

Zydus Cadila proposes Rs 1900 for three dose C-19 vaccine

With talks underway between the central government and Zydus Cadila over the pricing of the C-19 vaccine ZyCov-D, the pharma company is...
USFDA

Zydus Cadila gets USFDA nod for drug to treat Psoriasis

NEW DELHI: Drug firm Zydus Cadila said it has received approval from the US health regulator to market Apremilast tablets, used to...
USFDA

Zydus Cadila gets USFDA nod for Antidepressant drug

Zydus Cadila has received final approval from the USFDA to market Vortioxetine Tablets in the strengths of 5 mg, 10 mg, 20...
USFDA

Zydus Cadila gets tentative nod from USFDA for Brexpiprazole tablets

Zydus Cadila has received tentative approval from the US Food and Drug Administration (USFDA) to market Brexpiprazole tablets in the strength of...
USFDA

Zydus Cadila gets USFDA nod for Tofacitinib ER Tablets

Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market tofacitinib extended release tablets, 11 mg...

Here are some facts about Zydus Cadila’s Vaccine ZyCoV-D

Here are some facts about Zydus Cadila's Vaccine ZyCoV-D A day after getting the emergency use authorisation (EUA) in...
USFDA

Zydus Cadila gets USFDA nod for Mesalamine ER capsules

Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market mesalamine extended-release capsules in the strength...
USFDA

Zydus Cadila gets final nod from USFDA for Fulvestrant injection

Zydus Cadila has received the final approval from the US Food and Drug Administration (USFDA) to market Fulvestrant injection, 250 mg/5 mL...
Medicine Tablet

Zydus Cadila gets USFDA nod for Ibrutinib tablets

Zydus Cadila has received tentative approval from the US Food and Drug Administration (USFDA) to market Ibrutinib tablets, in the strengths of...
USFDA

Zydus Cadila gets USFDA nod for drug to treat HIV infection

Zydus Cadila has received final approval from US Food and Drug Administration (USFDA) to market emtricitabine and tenofovir disoproxil fumarate tablets, 100...
Zudus

Zydus Cadila gets tentative nod from USFDA for Pemetrexed for Injection

Zydus Cadila has received tentative approval from the USFDA to market Pemetrexed for Injection in the strengths of 100mg/vial, 500 mg/vial, and...
USFDA

Zydus Cadila gets tentative nod from USFDA for Fingolimod Capsules

Zydus Cadila has received tentative approval from the United States US (USFDA) to market Fingolimod capsules in the strength of 0.25 mg...
Medicine Tablet

Cadila Pharma launches Posaconazole to treat fungal diseases

Cadila Pharmaceuticals has launched a new triazole antifungal drug Posaconazole, which has been found to be effective against a wide range of...

Zydus Cadila gets tentative USFDA nod for Epilepsy drug

Zydus Cadila has received tentative approval from the USFDA to market Brivaracetam Tablets, in the strengths of 10 mg, 25 mg, 50...
Laboratory

Zydus Cadila gets nod for Clinical Trials of Antibodies cocktail

New Delhi: The only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatment of C-19 has been given...
USFDA

Zydus Cadila gets tentative USFDA nod for Osimertinib Tablets

Zydus Cadila has received tentative approval from the USFDA to market Osimertinib Tablets in the strengths of 40 mg and 80 mg...
Injection vaccine Medicine

Zydus Cadila plans to test its C-19 vaccine for 5-12 age group

After covering adults and children aged between 12 and 18 years under the ongoing clinical trials of its C-19 vaccine ZyKov-D, Zydus Cadila now plans to test its plasmid...
USFDA

Zydus Cadila gets USFDA nod for Fluphenazine HCL Tablets

Zydus Cadila has received final approval from the USFDA to market Fluphenazine Hydrochloride Tablets in the strengths of 1 mg, 2.5 mg,...

Zydus Cadila launches drug for Breast cancer treatment

Zydus Cadila, a global innovation driven healthcare company, launched trastuzumab emtansine, the first antibody drug conjugate (ADC) biosimilar and a highly effective...
Zudus

Zydus Cadila’s Virafin priced at Rs 11,995 per dose

As per reports, Zydus Cadila has fixed the price of Virafin, a medicine that has received EUA for C-19 treatment, at Rs...
Zudus

Zydus Cadila gets final USFDA nod for drug to treat High BP

Zydus Cadila has received final approval from the USFDA to market Macitentan Tablets, 10 mg (US RLD: Opsumit Tablets).
Zudus

Zydus Cadila seeks DCGI nod for Hepatitis drug use in C-19 patient

Dr. VG Somani, DCGI New Delhi: Zydus Cadila has submitted its application to Dr V.G. Somani the Drugs...
Recall

Zydus Cadila, Alembic Pharma recall these 2 drugs in US

US-based units of Zydus Cadila and Alembic Pharmaceuticals are recalling one drug each in the US after receiving complaints against the products.

Latest posts

Surgeons successfully test Pig Kidney transplant in human patient

New York: For the first time, a pig kidney has been transplanted into a human without triggering immediate rejection by the recipient's...

Authors

50 POSTS0 COMMENTS
30 POSTS0 COMMENTS
16 POSTS0 COMMENTS
15 POSTS0 COMMENTS
11 POSTS0 COMMENTS
9 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
4 POSTS0 COMMENTS
4 POSTS0 COMMENTS
3 POSTS0 COMMENTS
2 POSTS0 COMMENTS
2 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS